Revenue | ₹1,015.05Cr |
Net Profits | ₹262.87Cr |
Net Profit Margins | 25.90% |
Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 5.51% since last year same period to ₹1,015.05Cr in the Q4 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 3.1% jump in its revenue since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 35.17% since last year same period to ₹262.87Cr in the Q4 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 14.35% jump in its net profits since last 3-months.
Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 28.11% since last year same period to 25.90% in the Q4 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated 10.91% jumped in its net profit margins since last 3-months.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was ₹1,015.05Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was ₹262.87Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2024 was 25.90%.
The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was ₹962.03Cr.
The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was ₹194.48Cr.
The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q4 results 2023 was 20.22%.